Logo image of SHR.DE

SCHINDLER HOLDING AG-REG (SHR.DE) Stock Fundamental Analysis

FRA:SHR - Deutsche Boerse Ag - CH0024638212 - Common Stock - Currency: EUR

299  -2.5 (-0.83%)

Fundamental Rating

6

Overall SHR gets a fundamental rating of 6 out of 10. We evaluated SHR against 109 industry peers in the Machinery industry. Both the health and profitability get an excellent rating, making SHR a very profitable company, without any liquidiy or solvency issues. SHR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

SHR had positive earnings in the past year.
In the past year SHR had a positive cash flow from operations.
Each year in the past 5 years SHR has been profitable.
In the past 5 years SHR always reported a positive cash flow from operatings.
SHR.DE Yearly Net Income VS EBIT VS OCF VS FCFSHR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

SHR has a better Return On Assets (7.92%) than 83.64% of its industry peers.
SHR has a Return On Equity of 19.18%. This is amongst the best in the industry. SHR outperforms 85.45% of its industry peers.
SHR has a better Return On Invested Capital (16.30%) than 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SHR is significantly above the industry average of 9.09%.
The 3 year average ROIC (14.96%) for SHR is below the current ROIC(16.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.92%
ROE 19.18%
ROIC 16.3%
ROA(3y)6.91%
ROA(5y)6.86%
ROE(3y)17.36%
ROE(5y)17.97%
ROIC(3y)14.96%
ROIC(5y)14.99%
SHR.DE Yearly ROA, ROE, ROICSHR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 8.45%, SHR is in the better half of the industry, outperforming 79.09% of the companies in the same industry.
In the last couple of years the Profit Margin of SHR has grown nicely.
SHR has a better Operating Margin (11.27%) than 77.27% of its industry peers.
SHR's Operating Margin has been stable in the last couple of years.
SHR has a worse Gross Margin (34.65%) than 60.91% of its industry peers.
In the last couple of years the Gross Margin of SHR has remained more or less at the same level.
Industry RankSector Rank
OM 11.27%
PM (TTM) 8.45%
GM 34.65%
OM growth 3Y2.48%
OM growth 5Y0.14%
PM growth 3Y4.69%
PM growth 5Y2%
GM growth 3Y1.62%
GM growth 5Y0.44%
SHR.DE Yearly Profit, Operating, Gross MarginsSHR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

8

2. Health

2.1 Basic Checks

SHR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SHR has less shares outstanding
Compared to 5 years ago, SHR has less shares outstanding
SHR has a worse debt/assets ratio than last year.
SHR.DE Yearly Shares OutstandingSHR.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SHR.DE Yearly Total Debt VS Total AssetsSHR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 4.81 indicates that SHR is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.81, SHR belongs to the best of the industry, outperforming 88.18% of the companies in the same industry.
SHR has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
SHR has a Debt to FCF ratio of 0.55. This is amongst the best in the industry. SHR outperforms 90.91% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that SHR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.09, SHR belongs to the top of the industry, outperforming 82.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.55
Altman-Z 4.81
ROIC/WACC3.31
WACC4.92%
SHR.DE Yearly LT Debt VS Equity VS FCFSHR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

SHR has a Current Ratio of 1.42. This is a normal value and indicates that SHR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.42, SHR is in line with its industry, outperforming 40.91% of the companies in the same industry.
A Quick Ratio of 1.22 indicates that SHR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.22, SHR is in the better half of the industry, outperforming 62.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.22
SHR.DE Yearly Current Assets VS Current LiabilitesSHR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.30% over the past year.
SHR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.85% yearly.
Looking at the last year, SHR shows a decrease in Revenue. The Revenue has decreased by -2.24% in the last year.
The Revenue has been decreasing by -0.06% on average over the past years.
EPS 1Y (TTM)7.3%
EPS 3Y3.35%
EPS 5Y1.85%
EPS Q2Q%17.35%
Revenue 1Y (TTM)-2.24%
Revenue growth 3Y0%
Revenue growth 5Y-0.06%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SHR will show a small growth in Earnings Per Share. The EPS will grow by 6.96% on average per year.
Based on estimates for the next years, SHR will show a small growth in Revenue. The Revenue will grow by 3.18% on average per year.
EPS Next Y7.13%
EPS Next 2Y7.67%
EPS Next 3Y7.95%
EPS Next 5Y6.96%
Revenue Next Year0.74%
Revenue Next 2Y2.29%
Revenue Next 3Y2.99%
Revenue Next 5Y3.18%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SHR.DE Yearly Revenue VS EstimatesSHR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
SHR.DE Yearly EPS VS EstimatesSHR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.03, the valuation of SHR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SHR is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.35, SHR is valued at the same level.
Based on the Price/Forward Earnings ratio of 25.94, the valuation of SHR can be described as expensive.
72.73% of the companies in the same industry are cheaper than SHR, based on the Price/Forward Earnings ratio.
SHR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 29.03
Fwd PE 25.94
SHR.DE Price Earnings VS Forward Price EarningsSHR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

69.09% of the companies in the same industry are cheaper than SHR, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as SHR.
Industry RankSector Rank
P/FCF 20.42
EV/EBITDA 16.04
SHR.DE Per share dataSHR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHR does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of SHR may justify a higher PE ratio.
PEG (NY)4.07
PEG (5Y)15.69
EPS Next 2Y7.67%
EPS Next 3Y7.95%

5

5. Dividend

5.1 Amount

SHR has a Yearly Dividend Yield of 2.08%.
SHR's Dividend Yield is a higher than the industry average which is at 2.43.
Compared to an average S&P500 Dividend Yield of 2.42, SHR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

The dividend of SHR has a limited annual growth rate of 4.60%.
Dividend Growth(5Y)4.6%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

SHR pays out 56.63% of its income as dividend. This is a bit on the high side, but may be sustainable.
SHR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.63%
EPS Next 2Y7.67%
EPS Next 3Y7.95%
SHR.DE Yearly Income VS Free CF VS DividendSHR.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
SHR.DE Dividend Payout.SHR.DE Dividend Payout, showing the Payout Ratio.SHR.DE Dividend Payout.PayoutRetained Earnings

SCHINDLER HOLDING AG-REG

FRA:SHR (6/18/2025, 7:00:00 PM)

299

-2.5 (-0.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-18 2025-07-18
Inst Owners43.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.23B
Analysts71.43
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend5.32
Dividend Growth(5Y)4.6%
DP56.63%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.16%
Min EPS beat(2)13.77%
Max EPS beat(2)32.54%
EPS beat(4)4
Avg EPS beat(4)13.65%
Min EPS beat(4)2.21%
Max EPS beat(4)32.54%
EPS beat(8)8
Avg EPS beat(8)24.26%
EPS beat(12)12
Avg EPS beat(12)22.67%
EPS beat(16)15
Avg EPS beat(16)20.61%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.03
Fwd PE 25.94
P/S 2.7
P/FCF 20.42
P/OCF 19.02
P/B 6.13
P/tB 8.58
EV/EBITDA 16.04
EPS(TTM)10.3
EY3.44%
EPS(NY)11.52
Fwd EY3.85%
FCF(TTM)14.64
FCFY4.9%
OCF(TTM)15.72
OCFY5.26%
SpS110.72
BVpS48.82
TBVpS34.86
PEG (NY)4.07
PEG (5Y)15.69
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 19.18%
ROCE 20.51%
ROIC 16.3%
ROICexc 48.08%
ROICexgc 148.65%
OM 11.27%
PM (TTM) 8.45%
GM 34.65%
FCFM 13.23%
ROA(3y)6.91%
ROA(5y)6.86%
ROE(3y)17.36%
ROE(5y)17.97%
ROIC(3y)14.96%
ROIC(5y)14.99%
ROICexc(3y)41.07%
ROICexc(5y)40.5%
ROICexgc(3y)123.39%
ROICexgc(5y)114.34%
ROCE(3y)18.87%
ROCE(5y)18.94%
ROICexcg growth 3Y10.08%
ROICexcg growth 5Y16.08%
ROICexc growth 3Y4.66%
ROICexc growth 5Y4.57%
OM growth 3Y2.48%
OM growth 5Y0.14%
PM growth 3Y4.69%
PM growth 5Y2%
GM growth 3Y1.62%
GM growth 5Y0.44%
F-Score7
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.55
Debt/EBITDA 0.28
Cap/Depr 33.03%
Cap/Sales 0.97%
Interest Coverage 43.66
Cash Conversion 99.94%
Profit Quality 156.42%
Current Ratio 1.42
Quick Ratio 1.22
Altman-Z 4.81
F-Score7
WACC4.92%
ROIC/WACC3.31
Cap/Depr(3y)33.35%
Cap/Depr(5y)35.4%
Cap/Sales(3y)1%
Cap/Sales(5y)1.1%
Profit Quality(3y)127.63%
Profit Quality(5y)145.02%
High Growth Momentum
Growth
EPS 1Y (TTM)7.3%
EPS 3Y3.35%
EPS 5Y1.85%
EPS Q2Q%17.35%
EPS Next Y7.13%
EPS Next 2Y7.67%
EPS Next 3Y7.95%
EPS Next 5Y6.96%
Revenue 1Y (TTM)-2.24%
Revenue growth 3Y0%
Revenue growth 5Y-0.06%
Sales Q2Q%N/A
Revenue Next Year0.74%
Revenue Next 2Y2.29%
Revenue Next 3Y2.99%
Revenue Next 5Y3.18%
EBIT growth 1Y8.38%
EBIT growth 3Y2.48%
EBIT growth 5Y0.08%
EBIT Next Year29.68%
EBIT Next 3Y14.14%
EBIT Next 5Y11.06%
FCF growth 1Y27.12%
FCF growth 3Y7.93%
FCF growth 5Y10.26%
OCF growth 1Y25.49%
OCF growth 3Y6.67%
OCF growth 5Y6.12%